These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34348616)

  • 1. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
    Parashar P; Singh N; Alka ; Maurya P; Saraf SA
    Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles.
    Kang H; Mintri S; Menon AV; Lee HY; Choi HS; Kim J
    Nanoscale; 2015 Dec; 7(45):18848-62. PubMed ID: 26528835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 5. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface Engineering of Nanoparticles toward Cancer Theranostics.
    Huang P; Wang C; Deng H; Zhou Y; Chen X
    Acc Chem Res; 2023 Jul; 56(13):1766-1779. PubMed ID: 37314368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications.
    Balas M; Predoi D; Burtea C; Dinischiotu A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.
    Rahimkhoei V; Alzaidy AH; Abed MJ; Rashki S; Salavati-Niasari M
    Adv Colloid Interface Sci; 2024 Jul; 329():103204. PubMed ID: 38797070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
    J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular imaging with theranostic nanoparticles.
    Jokerst JV; Gambhir SS
    Acc Chem Res; 2011 Oct; 44(10):1050-60. PubMed ID: 21919457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional porous silicon nanoparticles for cancer theranostics.
    Wang CF; Sarparanta MP; Mäkilä EM; Hyvönen ML; Laakkonen PM; Salonen JJ; Hirvonen JT; Airaksinen AJ; Santos HA
    Biomaterials; 2015 Apr; 48():108-18. PubMed ID: 25701036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bispyrene-Based Self-Assembled Nanomaterials: In Vivo Self-Assembly, Transformation, and Biomedical Effects.
    He PP; Li XD; Wang L; Wang H
    Acc Chem Res; 2019 Feb; 52(2):367-378. PubMed ID: 30653298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.
    Kojima R; Aubel D; Fussenegger M
    Curr Opin Chem Biol; 2015 Oct; 28():29-38. PubMed ID: 26056952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinspired theranostic quantum dots: Paving the road to a new paradigm for cancer diagnosis and therapeutics.
    Mazahir F; Sharma R; Yadav AK
    Drug Discov Today; 2023 Dec; 28(12):103822. PubMed ID: 37949429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle theranostics in cardiovascular inflammation.
    MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P
    Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
    Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.